Haverford Financial Services’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
Sell
-4,444
Closed -$548K 72
2021
Q4
$548K Sell
4,444
-3,698
-45% -$484K 0.12% 60
2021
Q3
$1.16M Hold
8,142
0.28% 42
2021
Q2
$1.27M Hold
8,142
0.31% 38
2021
Q1
$1.26M Hold
8,142
0.33% 40
2020
Q4
$1.22M Hold
8,142
0.33% 35
2020
Q3
$1.08M Hold
8,142
0.33% 36
2020
Q2
$944K Buy
+8,142
New +$938K 0.32% 37
2019
Q1
Sell
-2,235
Closed -$225K 70
2018
Q4
$225K Sell
2,235
-2,730
-55% -$307K 0.09% 62
2018
Q3
$634K Hold
4,965
0.22% 45
2018
Q2
$537K Hold
4,965
0.2% 48
2018
Q1
$526K Buy
+4,965
New +$577K 0.2% 47

Other funds holding ZBH

Haverford Financial Services's ZBH Position: Q1 2022 in Review

Haverford Financial Services sold out of Zimmer Biomet (ZBH) in Q1 2022, closing a stake of 4,444 shares — an estimated $548K sold.

Haverford Financial Services first reported a position in ZBH in Q1 2018 and held it in 11 quarters. The position peaked at $1.27M in Q2 2021. 977 funds tracked by Wall St. Rank hold ZBH as of Q1 2022.

  • Haverford Financial Services reported no remaining Zimmer Biomet position as of Q1 2022 after selling out during the quarter.
  • Haverford Financial Services sold 4,444 Zimmer Biomet shares in Q1 2022, an estimated $548K.
  • Haverford Financial Services first reported a position in Zimmer Biomet in Q1 2018 and held it in 11 quarters.
  • Haverford Financial Services's Zimmer Biomet position peaked at $1.27M in Q2 2021.
  • 977 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2022.

Based on Haverford Financial Services's 13F filing for Q1 2022, filed 2 May 2022.